Stay updated on Efficacy & Safety of M2951 in Relapsing MS Clinical Trial

Sign up to get notified when there's something new on the Efficacy & Safety of M2951 in Relapsing MS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efficacy & Safety of M2951 in Relapsing MS Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and the prior Revision: v3.4.1 notice was removed; the page now reflects the current revision status.
    Difference
    0.2%
    Check dated 2026-02-11T14:15:48.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding with links to cc.nih.gov and opm.gov was added. The release notes show Revision: v3.4.1, replacing v3.4.0.
    Difference
    0.2%
    Check dated 2026-02-04T10:20:22.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Show glossary has been added to the page, and new labels include 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data,' along with a Revision: v3.4.0 note. The corresponding older labels 'Last Update Submitted that met QC Criteria,' 'No FEAR Act data,' and Revision: v3.3.4 have been removed.
    Difference
    0.1%
    Check dated 2026-01-28T05:10:03.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Added Revision: v3.3.4 and removed Revision: v3.3.3 from the page interface. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:06:44.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Footer updates: added Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2.
    Difference
    0.1%
    Check dated 2025-12-23T17:08:10.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    The Publications section was updated to state that publications are provided voluntarily by the study entrants and are automatically filled from PubMed, and the revision version changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T16:51:06.000Z thumbnail image

Stay in the know with updates to Efficacy & Safety of M2951 in Relapsing MS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efficacy & Safety of M2951 in Relapsing MS Clinical Trial page.